Biotechnology

EB Research Partnership and EB Research Foundation Come Together as Largest Global Organization Advancing Research for Epidermolysis Bullosa

As the leading EB research funders worldwide, the group will combine to leverage EBRP's innovative business model to accelerate treatments and cures NEW YORK and MELBOURNE, Australia, Oct. 9, 2020 /PRNewswire/ -- EB Research Partnership (EBRP), based inNew York, and EB Research Foundation (EBRF) ...

2020-10-08 21:00 2564

Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant

- Membrane manufacturing facility for aseptic filters will help meet customer demand in the growing biopharmaceutical market - Investment of more than € 140 million creates approximately 55 new jobs - Construction expected to be completed in 2022 DARMSTADT, Germany, Oct. 8, 2020 /PRNewswire/ --...

2020-10-08 20:30 4093

ITRI's Tech Innovation for COVID-19 Featured on Discovery Channel

TAIPEI, Oct. 8, 2020 /PRNewswire/ -- "Taiwan Revealed", a TV documentary series produced by Discovery Channel, premiered today inTaipei, highlighting Taiwan's technological innovations including the iPMx Molecular Rapid Test System developed byIndustrial Technology Research Institute(ITRI) <...

2020-10-08 17:17 4831

Milu Labs Wins Major Female-Focused Tech Competition in Thailand

BANGKOK, Oct. 8, 2020 /PRNewswire/ -- Milu Labs, an innovative biotech company focused exclusively on women's health, has won 1st place in the She Loves Tech Thailand startup competition. Milu Labs - Winner of She Loves Tech Thailand She Love...

2020-10-08 11:00 4040

Firmenich & Novozymes partner for great-tasting yogurt with unprecedented sugar reduction performance

New TasteGEM® SWL with Saphera® enables up to 50% sugar reduction without the use of sweeteners - while keeping a natural sweet taste GENEVA, Oct. 7, 2020 /PRNewswire/ -- Sugar reduction leader Firmenich, the world's largest privately owned perfume and taste company, and Danish biological soluti...

2020-10-07 20:00 3886

Nagase R&D Center Increases Productivity of Rare Amino Acid "Ergothioneine" 1000-fold: Highest Production Efficiency Reported Using "Smart Cell" Technology

TOKYO, Oct. 7, 2020 /PRNewswire/ -- The Nagase R&D Center, the research and development arm of NAGASE & CO., LTD. based inTokyo, has been developing fermentative production technology for ergothioneine (EGT) (*1) and researching EGT's functions. Using revolutionary biotechnology developed as part...

2020-10-07 14:00 1920

First Commercial Drug Manufactured via Ajinomoto Bio-Pharma Services' AJIPHASE Technology Receives FDA Approval

TOKYO, Oct. 6, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that the US FDA has approved the first commercial drug manufactured via Aji Bio-Pharma's proprietar...

2020-10-06 22:20 3077

Thailand's Eastern Economic Corridor to Become Post-COVID Global Food Innovation Hub

BANGKOK, Oct. 6, 2020 /PRNewswire/ -- Thailand's high-tech Eastern Economic Corridor (EEC), already positioning itself as the gateway toAsia, is aiming for a new post-COVID-19 role as incubator of innovative food products to nourish the world, officials said.

2020-10-06 12:18 4951

CARsgen Therapeutics Granted Orphan Drug Designation by the US FDA for CT041 CLDN18.2 CAR-T Cells for the Treatment of Gastric and Gastroesophageal Junction Cancers

SHANGHAI, Oct. 5, 2020 /PRNewswire/ -- CARsgen Therapeutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced thatthe United States (US) Food and Drug Administration (FDA) has granted orphan drug designation to one of CARsgen's first-in-class drug candidates, CT041, for the t...

2020-10-05 18:00 4603

Happiness Biotech Announced Receipt of FDA Registration For Its Hand Sanitizer

NANPING, China, Oct. 1, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company's hand sanitizer products have been registered with U.S. Food and Drug Administra...

2020-10-01 22:00 12864

OriCiro Launches World's First Cell-Free Amplification Technology for Large Circular DNA

TOKYO, Sept. 30, 2020 /PRNewswire/ -- OriCiro Genomics, a pioneer in the cell-free synthesis and amplification of genome-scale large DNA for gene therapy and synthetic biology, has today launched the OriCiroTM Cell-Free Cloning System, the world's first technology enabling cell-free amplification...

2020-09-30 21:47 3016

Firmenich Opens New Era in Ingredient Creation with Launch of Biotech and Naturals Pilot Plant in Geneva

GENEVA, Switzerland, Sept. 30, 2020 /PRNewswire/ -- Firmenich, the world's largest privately-owned Perfume and Taste company, is proud to announce the opening of its new biotechnology and naturals pilot plant and laboratory in Geneva. Benefiting from the latest digital technology, the facility ope...

2020-09-30 21:36 3408

TaiGen Biotechnology Out-Licensed Taigexyn (Nemonoxacin) to Luminarie Canada for Canada, Australia and New Zealand

TAIPEI, Sept. 30, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen")(Taiwan: 4157) today announced that they have signed an exclusive licensing agreement with Luminarie Canada Inc. ("Luminarie"), a leading Canadian pharmaceutical company, to develop and commercialize Taigexyn® ...

2020-09-30 15:51 1608

ILIAS Biologics Closes $20.6 Million Series B Financing

DAEJEON, South Korea, Sept. 28, 2020 /PRNewswire/ -- ILIAS Biologics Inc. (the "Company" or "ILIAS"), a leading exosome-based therapeutics company, announced today that the Company has completed a Series B financing round of$20.6 million inSouth Korea. The initial investors from the Series A rou...

2020-09-28 19:00 1576

World's first clinical trial of non-viral PD1 specific targeted CAR T therapy achieves great breakthroughs

SHANGHAI, Sept. 28, 2020 /PRNewswire/ -- On September 25, 2020, BIORAY LABORATORIES Inc. ("Bioraylab"), a company specialized in gene therapy and cell drug R&D, announced for the first time that clinical trials of non-viral PD1 specific targeted CAR T therapy in relapsed/refractory B-cell non-Hod...

2020-09-28 19:00 1461

Carmine Therapeutics named as one of FierceBiotech's "Fierce 15" Biotech Companies of 2020

CAMBRIDGE, Mass., Sept. 28, 2020 /PRNewswire/ -- Carmine Therapeutics announced today that it has been named by FierceBiotech as one of 2020's Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry.  The 2020 Fierce 15 com...

2020-09-28 18:00 1286

TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Injection) ORIENT-32 Study Met Its Primary Endpoints of Progression-Free Survival and Overall Survival in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma (HCC)

SAN FRANCISCO and SUZHOU, China, Sept. 28, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major d...

2020-09-28 10:15 5805

InventisBio Announces $147 Million Series D Financing Led by Hillhouse Affiliate GL Ventures

SHANGHAI, Sept. 28, 2020 /PRNewswire/ -- InventisBio, a clinical stage biotech company dedicated to the research and development of innovative small molecule drugs, announced the recent completion of a$147 million series D financing which has attracted participation of many top biopharmaceutical ...

2020-09-28 05:00 3811

Radius Health & Menarini Group Provide Elacestrant Update

Target enrollment milestone reached in the Phase 3 EMERALD study Life cycle planning advancing in parallel with current Phase 3 monotherapy program WALTHAM, Mass. and FLORENCE, Italy, Sept. 25, 2020 /PRNewswire/ -- -Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS) and the Menari...

2020-09-25 18:15 6345

Neurophth Therapeutics' Treatment of Leber's Hereditary Optic Neuropathy Gene Therapy NR082 was Granted Orphan Drug Designation by U.S. FDA

NEWARK, Del., Sept. 24, 2020 /PRNewswire/ -- Neurophth Therapeutics, Inc., (hereinafter referred to as "Neurophth") today announced that its leading candidate, NR082 (rAAV2-ND4, NFS-01 project), was granted an orphan drug designation (ODD) by the U.S. FDA for the treatment of Leber's Hereditary O...

2020-09-25 10:37 2057
1 ... 228229230231232233234 ... 275

Week's Top Stories